Neuralink

Healthtech · Brain-computer interface · Late growth · US

Valuation: $9Bunverified mark
Deal Score: C+60 / 100
Funding: ~$1.3B total across 6 rounds ($650M Series E latest)
Demand: High
IPO window: No plans stated
Top-100 rank: #9View ranking →

Open requests 0

Sell offers are visible to signed-in members.Sign in

Valuations are as reported and not verified (this one: unverified mark). Deal Score (0-100, graded A+ to C) is Mindcap's own assessment; demand is our desk's read of buyer and seller interest (Emerging, Medium, High). Data as of August 2026. Not investment advice.